Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis
Cross-sectional studies support an association between depression and inflammatory markers. However, little is known of their relationship in the context of antidepressant treatment. Our aim was to explore via meta-analysis whether antidepressant treatment is associated with a reduction in three inf...
Gespeichert in:
| Veröffentlicht in: | Psychological medicine 2012-10, Vol.42 (10), p.2015-2026 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2026 |
|---|---|
| container_issue | 10 |
| container_start_page | 2015 |
| container_title | Psychological medicine |
| container_volume | 42 |
| creator | Hiles, S. A. Baker, A. L. de Malmanche, T. Attia, J. |
| description | Cross-sectional studies support an association between depression and inflammatory markers. However, little is known of their relationship in the context of antidepressant treatment. Our aim was to explore via meta-analysis whether antidepressant treatment is associated with a reduction in three inflammatory markers associated with depression.
A computerized search of EMBASE, Medline, PsycINFO and Cochrane Library databases was completed using subject headings for depression and either interleukin-6, C-reactive protein or interleukin-10, selecting studies which reported circulating levels of inflammatory markers before and after antidepressant treatment for people with depression. Outcome and moderator variables were coded for analysis, including inflammatory marker change, depression severity change, age, gender ratio, assay brand, treatment response and weight change.
Pooled effect sizes showed a significant decrease in interleukin-6 (n=14, d=-0.42, p=0.02), marginally significant decrease in C-reactive protein (n=8, d=-0.57, p=0.05) and a non-significant decrease in interleukin-10 (n=3, d=-0.45, p=0.14) after treatment. High levels of heterogeneity were observed, which may be associated with clinical variations between the studies such as weight gain, anxiety, incomplete remission and other individual differences and co-morbidities.
The findings of this meta-analysis indicate that there may be a normalization of overactive inflammatory processes following antidepressant treatment. |
| doi_str_mv | 10.1017/S0033291712000128 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1417549413</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0033291712000128</cupid><sourcerecordid>2858701181</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-bf90da8aeb853bb056de7b277f31b131359792df8191306b9fbd86394bf093433</originalsourceid><addsrcrecordid>eNqNkUtrFjEUhoMo9rP6A9xIQIQuHM1JZpJJd_JRbaHQhboekpkTTZ2bSUbpxt_eDB21WISucsJ53vfcCHkO7A0wUG8_MiYE16CAM8aA1w_IDkqpi1qr-iHZrelizR-QJzFeZkRAyR-TA86FkKWQO_LrbEwYely--bGQr-m-CGja5H8gncOU0I_UjB31tyhg1Lj8zYnkO5wDxphDmrIyDZijLJpxmnukP336SjfGT-MxNXTAZAozmv4q-viUPHKmj_hsew_J5_cnn_anxfnFh7P9u_OirSRLhXWadaY2aOtKWMsq2aGyXCknwOahRKWV5p2rQYNg0mpnu1oKXVrHtCiFOCRHN755qO8LxtQMPrbY92bEaYkNlKCqUpdwD1RUUgvJ1T1QztdNM15m9OU_6OW0hLyFlZJSqRr4agg3VBumGAO6Zg5-MOGqAdasJ2_unDxrXmzOix2w-6P4feMMvNoAE1vTu2DG1se_nBRMQ7Uaia24GWzw3Re81eN_y18DnJnBHA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1266778123</pqid></control><display><type>article</type><title>Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis</title><source>MEDLINE</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Cambridge University Press Journals Complete</source><creator>Hiles, S. A. ; Baker, A. L. ; de Malmanche, T. ; Attia, J.</creator><creatorcontrib>Hiles, S. A. ; Baker, A. L. ; de Malmanche, T. ; Attia, J.</creatorcontrib><description>Cross-sectional studies support an association between depression and inflammatory markers. However, little is known of their relationship in the context of antidepressant treatment. Our aim was to explore via meta-analysis whether antidepressant treatment is associated with a reduction in three inflammatory markers associated with depression.
A computerized search of EMBASE, Medline, PsycINFO and Cochrane Library databases was completed using subject headings for depression and either interleukin-6, C-reactive protein or interleukin-10, selecting studies which reported circulating levels of inflammatory markers before and after antidepressant treatment for people with depression. Outcome and moderator variables were coded for analysis, including inflammatory marker change, depression severity change, age, gender ratio, assay brand, treatment response and weight change.
Pooled effect sizes showed a significant decrease in interleukin-6 (n=14, d=-0.42, p=0.02), marginally significant decrease in C-reactive protein (n=8, d=-0.57, p=0.05) and a non-significant decrease in interleukin-10 (n=3, d=-0.45, p=0.14) after treatment. High levels of heterogeneity were observed, which may be associated with clinical variations between the studies such as weight gain, anxiety, incomplete remission and other individual differences and co-morbidities.
The findings of this meta-analysis indicate that there may be a normalization of overactive inflammatory processes following antidepressant treatment.</description><identifier>ISSN: 0033-2917</identifier><identifier>EISSN: 1469-8978</identifier><identifier>DOI: 10.1017/S0033291712000128</identifier><identifier>PMID: 22336436</identifier><identifier>CODEN: PSMDCO</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Adult and adolescent clinical studies ; Age ; Antidepressant drugs ; Antidepressants ; Antidepressive Agents - blood ; Antidepressive Agents - therapeutic use ; Anxiety ; Biological and medical sciences ; C-Reactive Protein ; Clinical outcomes ; Cross-Sectional Studies ; Cytokines ; Depression ; Depressive Disorder - blood ; Depressive Disorder - complications ; Heterogeneity ; Humans ; Inflammation - blood ; Inflammation - complications ; Interleukin-10 - blood ; Interleukin-6 - blood ; Medical sciences ; Mental depression ; Meta-analysis ; Mood disorders ; Neuropharmacology ; Pharmacology. Drug treatments ; Proteins ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Systematic review ; Weight gain</subject><ispartof>Psychological medicine, 2012-10, Vol.42 (10), p.2015-2026</ispartof><rights>Copyright © Cambridge University Press 2012</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-bf90da8aeb853bb056de7b277f31b131359792df8191306b9fbd86394bf093433</citedby><cites>FETCH-LOGICAL-c560t-bf90da8aeb853bb056de7b277f31b131359792df8191306b9fbd86394bf093433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0033291712000128/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,780,784,12845,27923,27924,30998,30999,55627</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26309158$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22336436$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hiles, S. A.</creatorcontrib><creatorcontrib>Baker, A. L.</creatorcontrib><creatorcontrib>de Malmanche, T.</creatorcontrib><creatorcontrib>Attia, J.</creatorcontrib><title>Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis</title><title>Psychological medicine</title><addtitle>Psychol Med</addtitle><description>Cross-sectional studies support an association between depression and inflammatory markers. However, little is known of their relationship in the context of antidepressant treatment. Our aim was to explore via meta-analysis whether antidepressant treatment is associated with a reduction in three inflammatory markers associated with depression.
A computerized search of EMBASE, Medline, PsycINFO and Cochrane Library databases was completed using subject headings for depression and either interleukin-6, C-reactive protein or interleukin-10, selecting studies which reported circulating levels of inflammatory markers before and after antidepressant treatment for people with depression. Outcome and moderator variables were coded for analysis, including inflammatory marker change, depression severity change, age, gender ratio, assay brand, treatment response and weight change.
Pooled effect sizes showed a significant decrease in interleukin-6 (n=14, d=-0.42, p=0.02), marginally significant decrease in C-reactive protein (n=8, d=-0.57, p=0.05) and a non-significant decrease in interleukin-10 (n=3, d=-0.45, p=0.14) after treatment. High levels of heterogeneity were observed, which may be associated with clinical variations between the studies such as weight gain, anxiety, incomplete remission and other individual differences and co-morbidities.
The findings of this meta-analysis indicate that there may be a normalization of overactive inflammatory processes following antidepressant treatment.</description><subject>Adult and adolescent clinical studies</subject><subject>Age</subject><subject>Antidepressant drugs</subject><subject>Antidepressants</subject><subject>Antidepressive Agents - blood</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Anxiety</subject><subject>Biological and medical sciences</subject><subject>C-Reactive Protein</subject><subject>Clinical outcomes</subject><subject>Cross-Sectional Studies</subject><subject>Cytokines</subject><subject>Depression</subject><subject>Depressive Disorder - blood</subject><subject>Depressive Disorder - complications</subject><subject>Heterogeneity</subject><subject>Humans</subject><subject>Inflammation - blood</subject><subject>Inflammation - complications</subject><subject>Interleukin-10 - blood</subject><subject>Interleukin-6 - blood</subject><subject>Medical sciences</subject><subject>Mental depression</subject><subject>Meta-analysis</subject><subject>Mood disorders</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Proteins</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Systematic review</subject><subject>Weight gain</subject><issn>0033-2917</issn><issn>1469-8978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkUtrFjEUhoMo9rP6A9xIQIQuHM1JZpJJd_JRbaHQhboekpkTTZ2bSUbpxt_eDB21WISucsJ53vfcCHkO7A0wUG8_MiYE16CAM8aA1w_IDkqpi1qr-iHZrelizR-QJzFeZkRAyR-TA86FkKWQO_LrbEwYely--bGQr-m-CGja5H8gncOU0I_UjB31tyhg1Lj8zYnkO5wDxphDmrIyDZijLJpxmnukP336SjfGT-MxNXTAZAozmv4q-viUPHKmj_hsew_J5_cnn_anxfnFh7P9u_OirSRLhXWadaY2aOtKWMsq2aGyXCknwOahRKWV5p2rQYNg0mpnu1oKXVrHtCiFOCRHN755qO8LxtQMPrbY92bEaYkNlKCqUpdwD1RUUgvJ1T1QztdNM15m9OU_6OW0hLyFlZJSqRr4agg3VBumGAO6Zg5-MOGqAdasJ2_unDxrXmzOix2w-6P4feMMvNoAE1vTu2DG1se_nBRMQ7Uaia24GWzw3Re81eN_y18DnJnBHA</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Hiles, S. A.</creator><creator>Baker, A. L.</creator><creator>de Malmanche, T.</creator><creator>Attia, J.</creator><general>Cambridge University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20121001</creationdate><title>Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis</title><author>Hiles, S. A. ; Baker, A. L. ; de Malmanche, T. ; Attia, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-bf90da8aeb853bb056de7b277f31b131359792df8191306b9fbd86394bf093433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Age</topic><topic>Antidepressant drugs</topic><topic>Antidepressants</topic><topic>Antidepressive Agents - blood</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Anxiety</topic><topic>Biological and medical sciences</topic><topic>C-Reactive Protein</topic><topic>Clinical outcomes</topic><topic>Cross-Sectional Studies</topic><topic>Cytokines</topic><topic>Depression</topic><topic>Depressive Disorder - blood</topic><topic>Depressive Disorder - complications</topic><topic>Heterogeneity</topic><topic>Humans</topic><topic>Inflammation - blood</topic><topic>Inflammation - complications</topic><topic>Interleukin-10 - blood</topic><topic>Interleukin-6 - blood</topic><topic>Medical sciences</topic><topic>Mental depression</topic><topic>Meta-analysis</topic><topic>Mood disorders</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Proteins</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Systematic review</topic><topic>Weight gain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hiles, S. A.</creatorcontrib><creatorcontrib>Baker, A. L.</creatorcontrib><creatorcontrib>de Malmanche, T.</creatorcontrib><creatorcontrib>Attia, J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychological medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hiles, S. A.</au><au>Baker, A. L.</au><au>de Malmanche, T.</au><au>Attia, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis</atitle><jtitle>Psychological medicine</jtitle><addtitle>Psychol Med</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>42</volume><issue>10</issue><spage>2015</spage><epage>2026</epage><pages>2015-2026</pages><issn>0033-2917</issn><eissn>1469-8978</eissn><coden>PSMDCO</coden><abstract>Cross-sectional studies support an association between depression and inflammatory markers. However, little is known of their relationship in the context of antidepressant treatment. Our aim was to explore via meta-analysis whether antidepressant treatment is associated with a reduction in three inflammatory markers associated with depression.
A computerized search of EMBASE, Medline, PsycINFO and Cochrane Library databases was completed using subject headings for depression and either interleukin-6, C-reactive protein or interleukin-10, selecting studies which reported circulating levels of inflammatory markers before and after antidepressant treatment for people with depression. Outcome and moderator variables were coded for analysis, including inflammatory marker change, depression severity change, age, gender ratio, assay brand, treatment response and weight change.
Pooled effect sizes showed a significant decrease in interleukin-6 (n=14, d=-0.42, p=0.02), marginally significant decrease in C-reactive protein (n=8, d=-0.57, p=0.05) and a non-significant decrease in interleukin-10 (n=3, d=-0.45, p=0.14) after treatment. High levels of heterogeneity were observed, which may be associated with clinical variations between the studies such as weight gain, anxiety, incomplete remission and other individual differences and co-morbidities.
The findings of this meta-analysis indicate that there may be a normalization of overactive inflammatory processes following antidepressant treatment.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>22336436</pmid><doi>10.1017/S0033291712000128</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0033-2917 |
| ispartof | Psychological medicine, 2012-10, Vol.42 (10), p.2015-2026 |
| issn | 0033-2917 1469-8978 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1417549413 |
| source | MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); Cambridge University Press Journals Complete |
| subjects | Adult and adolescent clinical studies Age Antidepressant drugs Antidepressants Antidepressive Agents - blood Antidepressive Agents - therapeutic use Anxiety Biological and medical sciences C-Reactive Protein Clinical outcomes Cross-Sectional Studies Cytokines Depression Depressive Disorder - blood Depressive Disorder - complications Heterogeneity Humans Inflammation - blood Inflammation - complications Interleukin-10 - blood Interleukin-6 - blood Medical sciences Mental depression Meta-analysis Mood disorders Neuropharmacology Pharmacology. Drug treatments Proteins Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Systematic review Weight gain |
| title | Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A34%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin-6,%20C-reactive%20protein%20and%20interleukin-10%20after%20antidepressant%20treatment%20in%20people%20with%20depression:%20a%20meta-analysis&rft.jtitle=Psychological%20medicine&rft.au=Hiles,%20S.%20A.&rft.date=2012-10-01&rft.volume=42&rft.issue=10&rft.spage=2015&rft.epage=2026&rft.pages=2015-2026&rft.issn=0033-2917&rft.eissn=1469-8978&rft.coden=PSMDCO&rft_id=info:doi/10.1017/S0033291712000128&rft_dat=%3Cproquest_cross%3E2858701181%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1266778123&rft_id=info:pmid/22336436&rft_cupid=10_1017_S0033291712000128&rfr_iscdi=true |